UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  June 5, 2015

 

Diplomat Pharmacy, Inc.

(Exact Name of Registrant as Specified in its Charter)

 


 

Michigan
(State or Other Jurisdiction
of Incorporation)

 

001-36677
(Commission File Number)

 

38-2063100
(IRS Employer
Identification No.)

 

4100 S. Saginaw St.

Flint, Michigan 48507

(Address of Principal Executive Offices)  (Zip Code)

 

(888) 720-4450

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Performance-Based Stock Option Awards

 

On June 5, 2015, the Board of Directors of Diplomat Pharmacy, Inc. (the “Company”) approved a form of Stock Option Award Agreement (Performance-Based) (the “Option Award Agreement”) for options to be issued from time to time under the Company’s 2014 Omnibus Incentive Plan.  Under the terms of the Option Award Agreement, the Company may issue options to purchase a number of shares of common stock of the Company (the “Initial Option Shares”) which will be earned or forfeited based upon the Company’s performance relative to specified revenue and Adjusted EBITDA goals for the applicable year.  The earned options, if any, will vest in four annual installments, with the first installment vesting upon Audit Committee confirmation of the satisfaction of the applicable performance goals, and the remaining installments vesting annually thereafter.  The Option Award Agreement contains provisions regarding vesting, the ability to exercise vested options, and termination in the case of change in control events.  The Option Award Agreement also provides for termination of the award in certain cases of employment termination.  In addition, the Option Award includes a clawback provision that provides for the Company’s option to seek forfeiture of outstanding option awards (and proceeds from prior option exercises) for violations of certain agreements with the Company or future compensation recovery policies.  The Form of Stock Option Award Agreement (Performance-Based) is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

On June 5, 2015, the Company’s Board of Directors approved the issuance of performance-based option awards to certain employees, including each of the Company’s named executive officers in the following amounts:  Philip Hagerman, 154,392 Initial Option Shares; Sean Whelan, 27,019 Initial Option Shares; Gary Kadlec, 28,563 Initial Option Shares; Jeffrey Rowe, 16,057 Initial Option Shares; and Atheer Kaddis, 15,686 Initial Option Shares.  For 2015 option awards, the revenue and Adjusted EBTIDA performance goals represent 30% and 70%, respectively, of the target award.  Participants can earn 90% to 100% of each award component based on satisfying 90% to 100%, respectively, of such annual performance goal, with linear increases in between such range.

 

Annual Bonus Plan

 

On June 5, 2015, the Company’s Board of Directors approved the Diplomat Pharmacy, Inc. Annual Performance Bonus Plan (the “Bonus Plan”).  The Bonus Plan provides for annual incentive payments to the Company’s executive officers and certain other eligible key employees as determined by the Company’s chief executive officer.  The target bonus is based upon a specified percentage of the participant’s annual base salary.  The Bonus Plan specifies rights regarding pro rata bonuses or termination of such bonus upon hiring, promotion, employment termination or change in control events.  In addition, the Bonus Plan includes a clawback provision that provides for the Company’s option to seek reimbursement of up to three years of bonus payments in the event of a restatement of the Company’s financial statements due to error or misconduct, to the extent permitted by governing law, having the effect of reducing the earned bonus thereunder.  A copy of the Bonus Plan is attached hereto as Exhibit 10.2 and is incorporated herein by reference.

 

For executive officers, the Bonus Plan is based on the achievement of revenue, Adjusted EBITDA, and individual annual performance goals.  In 2015, such components represent 30%, 60% and 10%, respectively, of the target bonus.  Executive officers can earn up to 110% of the target bonus for each component in 2015.

 

Item 5.07   Submission of Matters to a Vote of Security Holders.

 

At the annual meeting of shareholders of the Company held on June 5, 2015, shareholders elected the two Class I director nominees for three-year terms, ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015, and approved (on an advisory basis) the Company’s named executive officer compensation.  On Proposal 4, shareholders provided the highest number of votes for an advisory vote on named executive officer compensation to be held annually.  Consistent with its recommendation in the Company’s 2015 proxy statement, the Board of Directors of the Company determined that the Company will hold an annual advisory vote on named executive officer compensation until the next required advisory vote on such frequency.  The annual meeting proposals were described in detail in the Company’s

 

2



 

definitive proxy statement filed on April 20, 2015 with the Securities and Exchange Commission.

 

The results of the voting are shown below.

 

Proposal 1 — Election of Directors

 

Class I Nominees

 

Votes For

 

Votes Withheld

 

Broker Non-Votes

 

Philip R. Hagerman

 

41,958,207

 

6,468,952

 

1,542,339

 

David Dreyer

 

47,471,309

 

955,850

 

1,542,339

 

 

Proposal 2—Ratification of the Appointment of Independent Registered Public Accounting Firm

 

Votes For

 

Votes Against

 

Abstain

 

49,902,856

 

55,013

 

11,629

 

 

Proposal 3 — Advisory Vote on Named Executive Officer Compensation

 

Votes For

 

Votes Against

 

Abstain

 

Broker Non-Votes

 

48,396,248

 

21,499

 

9,412

 

1,542,339

 

 

Proposal 4 — Advisory Vote on the Frequency of an Advisory Vote on Named Executive Officer Compensation

 

Once Every Year

 

Once Every
Two Years

 

Once Every
Three Years

 

Abstain

 

Broker Non-Votes

 

47,995,495

 

12,862

 

409,342

 

9,460

 

1,542,339

 

 

Item 9.01                                            Financial Statements and Exhibits.

 

(d)                                                                                                          Exhibits

 

No.

 

Description

10.1

 

Form of Stock Option Award Agreement (Performance-Based)

10.2

 

Diplomat Pharmacy, Inc. Annual Performance Bonus Plan

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Diplomat Pharmacy, Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Sean M. Whelan

 

 

 

Sean M. Whelan

 

 

 

Chief Financial Officer

 

Date: June 9, 2015

 

4



 

EXHIBIT INDEX

 

No.

 

Description

10.1

 

Form of Stock Option Award Agreement (Performance-Based)

10.2

 

Diplomat Pharmacy, Inc. Annual Performance Bonus Plan

 

5


Exhibit 10.1

 

DIPLOMAT PHARMACY, INC.

Form of Stock Option Award Agreement (Performance-Based)

Under 2014 Omnibus Incentive Plan

 

Grantee:

Grant Date:

Number of Option Shares:

Exercise Price per Option Share:

 

1.                                       Grant of Option .

 

(a)            Initial Grant .  Pursuant to the Diplomat Pharmacy, Inc. 2014 Omnibus Incentive Plan (the “ Plan ”), effective as of the Grant Date set forth above, Diplomat Pharmacy, Inc. (the “ Company ”) grants to the Grantee identified above an option (the “ Option ”) to purchase up to (but not in excess of)         shares of the Company’s common stock, no par value (the “ Initial Option Shares ”), at the Exercise Price per Option Share set forth above, on the terms and subject to the conditions set forth in this Stock Option Award Agreement (this “ Agreement ”) and in the Plan. The Option is intended to be a Non-qualified Stock Option. Capitalized terms not defined in this Agreement have the meanings ascribed to such terms in the Plan.

 

(b)            Performance Adjustment to Initial Option Shares .  The Initial Option Shares shall be earned and adjusted as follows:

 

(i)             Revenues .

 

(a)            The Company’s revenue performance goal for the year ended December 31,       is $              (the “ Revenue Performance Goal ”).

 

(b)            The Grantee will earn    % of the Initial Option Shares if the Company’s revenue is    % or more of the Revenue Performance Goal.

 

(c)            The Grantee will earn    % of the Initial Option Shares if the Company’s revenue is    % of the Revenue Performance Goal.

 

(d)            The Grantee will earn between    % and    % of the Initial Option Shares if the Company’s revenue is more than    % and less than    % of the Revenue Performance goal, with a linear increase in shares based on such performance.

 

(e)            The Grantee will forfeit    % of the Initial Option Shares if the Company’s revenue is less than    % of the Revenue Performance Goal.

 



 

(ii)            Adjusted EBITDA .

 

(a)            The Company’s Adjusted EBITDA performance goal for the year ended December 31,       (to be calculated in the same manner as in the Diplomat Pharmacy, Inc. Annual Performance Bonus Plan for the same performance year) is $              (the “ Adjusted EBITDA Performance Goal ”).

 

(b)            The Grantee will earn    % of the Initial Option Shares if the Company’s Adjusted EBITDA is    % or more of the Adjusted EBITDA Performance Goal.

 

(c)            The Grantee will earn    % of the Initial Option Shares if the Company’s Adjusted EBITDA is    % of the Adjusted EBITDA Performance Goal.

 

(d)            The Grantee will earn between    % and    % of the Initial Option Shares if the Company’s Adjusted EBITDA is more than    % and less than    % of the Adjusted EBITDA Performance goal, with a linear increase in shares based on such performance.

 

(e)            The Grantee will forfeit    % of the Initial Option Shares if the Company’s Adjusted EBITDA is less` than    % of the Adjusted EBITDA Performance Goal.

 

The Board or Compensation Committee shall round, up or down to the nearest whole number, the number of earned Initial Option Shares and the percentage achievement of the Revenue Performance Goal and Adjusted EBTIDA Performance Goal, in its sole discretion provided that it calculates such measures consistently for all Options with Grant Dates in the same year.

 

Following the Determination Date (defined below), the earned Initial Options Shares shall be referred to as the “ Option Shares .”

 

(c)            Timing of Adjustment Determination .  The adjustments specified in Section 1(b) will be determined as of the earlier of (i) the date the Company files its Annual Report on Form 10-K for the year ended December 31,     , which includes the audited financial statements for such year, with the Securities and Exchange Commission and (ii) if the filing contemplated by (i) is not made by March 31,       , the date the Audit Committee of the Board of Directors of the Company approves the financial statements of the Company for the year ended December 31,       (such actual date, the “ Determination Date ”).

 

2.              Term of Option .  The Option shall expire on the ten year anniversary of the Grant Date (the “ Expiration Date ”), subject to earlier expiration (i) in the event of a Change in Control as provided in Paragraph 4 below, or (ii) following termination of the Grantee’s employment with the Company or a Subsidiary as provided in Paragraph 6 below.

 

2



 

3.              Normal Vesting .   Grantee may exercise the Option only if and to the extent that the Option has become earned and vested. For this purpose and except as provided in Paragraphs 4  and 6   below, the Option shall become vested as to 25% of the Option Shares on the Determination Date and each of the first, second and third anniversaries of the Determination Date, provided that the Option shall cease vesting upon termination of Grantee’s employment with the Company or a Subsidiary for any reason whatsoever and the portion of the Option scheduled to vest on any such vesting date shall vest only if Grantee has remained continuously employed by the Company or a Subsidiary from the Grant Date to such vesting date.

 

4.              Accelerated Vesting upon Change in Control .  Notwithstanding Paragraph 3 above, if there is a Change in Control and if Grantee has remained continuously employed from the Grant Date to the date of the Change in Control, any then earned but unvested portion of the Option shall automatically become vested 10 days prior to the Change in Control. Except as otherwise provided by the Committee at the time of a Change in Control, any portion of the Option that has not, prior to or in connection with the Change in Control, either been exercised or (pursuant to Paragraph 12 of the Plan) cancelled in exchange for a cash payment equal to the fair value of the Option shall terminate, expire and be forfeited and of no further force or affect upon closing of the Change in Control.

 

5.              Procedure for Exercise and Payment of Exercise Price .  Grantee may exercise all or any portion of the Option, to the extent it is vested and outstanding, at any time prior to its expiration, by (i) delivering a properly executed written notice of exercise to the Company, in such form as shall be approved by the Company, specifying the number of Option Shares to be purchased, and (ii) paying to the Company the aggregate Exercise Price of the Option Shares to be purchased. Grantee shall pay the aggregate Exercise Price of the Option Shares to be purchased on exercise of the Option (i) by payment of such aggregate Exercise Price in cash or by certified or bank cashier’s check payable to the order of the Company, (ii) by delivery of irrevocable instructions to a stockbroker to sell immediately some or all of the Option Shares acquired by exercise of the Option and to promptly deliver to the Company an amount of the sale proceeds sufficient to pay the aggregate Exercise Price, or (iii) in the discretion of the Committee, by such other cashless means authorized by Paragraph 6(g) of the Plan.

 

6.              Termination of Employment .  Upon termination of Grantee’s employment with the Company or a Subsidiary for any reason, vesting of the Option shall terminate and any portion of the Option that is unearned or unvested at the time of termination of Grantee’s employment with the Company or a Subsidiary shall expire, terminate and be forfeited and of no further force or effect. If the Company or a Subsidiary terminates Grantee’s employment for Cause, any portion of the Option which is vested at the time of such termination shall also expire, terminate and be forfeited and of no further force or effect. If Grantee’s employment with the Company or a Subsidiary terminates due to the death or Disability of Grantee, any portion of the Option that is vested on the date of such termination may be exercised only during the one year period following such termination, but in no event after the Expiration Date. If Grantee’s employment with Company or a Subsidiary terminates for any reason other than death, Disability or Cause, any portion of the Option that is vested on the date of such termination may be exercised only during the 90 day period following such termination, but in no event after the Expiration Date.

 

3



 

7.              Non-Transferability of Option .  The Option is personal to Grantee. Unless permitted otherwise in the discretion of the Committee, the Option is not transferable by Grantee (other than by will or the laws of descent and distribution) and, during Grantee’s lifetime, only Grantee (or his guardian or legal representative) may exercise the Option. In the event of Grantee’s death, the Option may be exercised (i) by the executor or administrator of Grantee’s estate or the person or persons to whom Grantee’s rights under the Option shall pass by will or the laws of descent and distribution, and (ii) to the extent and during the period Grantee was allowed to exercise the Option at the date of Grantee’s death.

 

8.              Restrictive Covenants; Compensation Recovery .  By signing this Agreement, Grantee acknowledges and agrees that the Option, Initial Option Shares and the Option Shares (and any stock or stock-based award previously granted by the Company or a Subsidiary to Grantee under the Plan or otherwise) shall (i) be subject to forfeiture as a result of Grantee’s violation of any agreement with the Company or a Subsidiary regarding non-competition, non-solicitation, confidentiality, non-disparagement, inventions and/or similar restrictive covenants (the “ Restrictive Covenants Agreement ”), and (ii) be subject to forfeiture and/or recovery under any compensation recovery policy that may be adopted from time to time by the Company or any of its Subsidiaries. For avoidance of doubt, compensation recovery rights to the Initial Option Shares or Option Shares or other shares of Company stock (including shares of stock acquired under previously granted stock-based awards) shall extend to the proceeds realized by Grantee due to sale or other transfer of such stock. Grantee’s prior execution of the Restrictive Covenants Agreement was a material inducement for the Company’s grant of the Option under this Agreement.

 

9.              Conformity with Plan .  The Option is intended to conform in all respects with and is subject to all applicable provisions of the Plan, which is incorporated herein by reference. Any inconsistencies between the provisions of this Agreement and the Plan shall be resolved in accordance with the provisions of the Plan.

 

10.           Rights as a Participant .  Nothing contained in this Agreement shall (i) interfere with or limit in any way the right of the Company or a Subsidiary to terminate Grantee’s employment at any time and for any or no reason, (ii) confer upon Grantee any right to be selected again as a Plan Participant, or (iii) require or permit any adjustment to the number of Option Shares or to the Exercise Price upon or as a result of the occurrence of any subsequent event (except as provided in Paragraph 13 of the Plan).

 

11.           Withholding of Taxes .  Any income or employment tax required to be withheld upon exercise of the Option shall be paid by Grantee to the Company or a Subsidiary (whichever is the employer of Grantee), or the Company or a Subsidiary (whichever is the employer of Grantee) may withhold such tax from the cash compensation otherwise payable to Grantee. Alternatively, Grantee may pay any such withholding tax (i) by delivery of irrevocable instructions to a stockbroker to sell immediately some or all of the Option Shares acquired by exercise of the Option and to promptly deliver to the Company an amount of the sale proceeds sufficient to pay the withholding tax due on exercise of the Option, or (ii) such other cashless means as may be permitted under law and in the discretion of the Committee.

 

4



 

12.           Resale Restrictions .  The Company currently has an effective registration statement on file with the Securities and Exchange Commission with respect to the Option Shares. The Company currently intends to maintain this registration, but has no obligation to do so. If the registration ceases to be effective, Grantee will not be able to sell or transfer Option Shares issued to Grantee upon exercise of the Option unless an exemption from registration under applicable securities laws is available. Grantee agrees that any resale by Grantee of Option Shares acquired upon exercise of the Option shall comply in all respects with the requirements of all applicable securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act of 1933, as amended, the Exchange Act, and the respective rules and regulations promulgated thereunder) and any other law, rule or regulation applicable thereto, as such laws, rules and regulations may be amended from time to time. The Company shall not be obligated to issue the Option Shares or permit their resale if such issuance or resale would violate any such requirements.

 

13.           Consent to Transfer of Personal Data .  In administering this Agreement and the Plan, or to comply with applicable legal, regulatory, tax or accounting requirements, it may be necessary for the Company to transfer certain Grantee personal data to a Subsidiary, or  to outside service providers, or to governmental agencies. By signing this Agreement and accepting the award of the Option, Grantee consents, to the fullest extent permitted by law, to the use and transfer, electronically or otherwise, of Grantee’s personal data to such entities for such purposes.

 

14.           Consent to Electronic Delivery .  In lieu of receiving documents in hard copy paper format, Grantee agrees, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and all other agreements, documents, forms and communications) in connection with the Option and any other prior or future incentive award or program made or offered by the Company, a Subsidiary and their predecessors or successors. Electronic delivery of a document to Grantee may be via a Company or Subsidiary email system or by reference to a location on a Company or Subsidiary intranet site to which Grantee has access.

 

15.           No Ownership of Option Shares Until Exercise .  Prior to the Grantee’s exercise of the Option and purchase of the Option Shares, the Grantee shall not possess any incidents of ownership of the Option Shares, including voting or dividend rights.

 

16.           Notices .  Any and all notices, designations, consents, offers, acceptances and any other communications provided for herein shall be given in writing and shall be delivered either personally or by registered or certified mail, postage prepaid, which shall be addressed, in the case of the Company, to the Chief Financial Officer of the Company at the principal office of the Company and, in the case of the Grantee, to the Grantee’s address appearing on the books of the Company or to such other address as may be designated in writing by the Grantee.

 

17.           Successors .  The terms of this Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns, and of the Grantee and the beneficiaries, executors, administrators, heirs and successors of the Grantee.

 

5



 

18.           Invalid Provision .  The invalidity or unenforceability of any particular provision hereof shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provision had been omitted.

 

19.           Modifications .  Except as provided in the Plan, no change, modification or waiver of any provision of this Agreement shall be valid unless the same is in writing and signed by the parties hereto.

 

20.           Entire Agreement .  This Agreement and the Plan contain the entire agreement and understanding of the parties hereto with respect to the subject matter contained herein and therein and supersede all prior communications, representations and negotiations in respect thereto.

 

21.           Governing Law .  This Agreement and the rights of the Grantee hereunder shall be governed, construed, and administered in accordance with and governed by the laws of the State of Michigan (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws of such jurisdiction or any other jurisdiction).

 

22.           Headings .  The headings of the Paragraphs hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Agreement.

 

23.           Counterparts .  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

6



 

24.           Committee Determinations Final and Binding .  The Committee shall have final authority to interpret and construe the Plan and this Agreement and to make any and all determinations thereunder, and its decision shall be binding and conclusive upon the Grantee and his/her legal representative in respect of any questions arising under the Plan or this Agreement.

 

 

Very Truly Yours,

 

 

 

Diplomat Pharmacy, Inc.

 

 

 

 

 

By

 

 

 

 

 

Name:

 

 

Its:

 

 

The undersigned hereby acknowledges having read this Agreement and the Plan and agrees to be bound by all provisions set forth herein and in the Plan.

 

 

Dated as of:

 

 

GRANTEE:

 

 

 

 

 

 

 

Name:

 

 

7


Exhibit 10.2

 

Diplomat Pharmacy, Inc.
Annual Performance Bonus Plan

 

(Effective January 1, 2015)

 

1.              Purpose

 

The purpose of this Diplomat Pharmacy, Inc. Annual Performance Bonus Plan (the “ Plan ”) is to attract, motivate, reward and retain eligible employees by making a portion of their cash compensation (the “ Annual Incentive Payments ”) dependent on (i) the performance of Diplomat Pharmacy, Inc. (the “ Company ) , and (ii) individual performance.

 

2.              Participants

 

The individuals to whom Annual Incentive Payments may be made hereunder shall be the executive officers of the Company, as determined by the Company’s Board of Directors (the “ Executive Officer Participants ”), and such other key employees of the Company as the Chief Executive Officer shall determine in his or her sole discretion (the “ Other Participants ” and, together with the Executive Officer Participants, the “ Participants ”).

 

3.              The Committee

 

(a)            The Compensation Committee of the Board of Directors of the Company (the “ Committee ”) shall administer and interpret the Plan for the Executive Officer Participants.  The Chief Executive Officer shall administer and interpret the Plan for the Other Participants.  The Committee and the Chief Executive Officer, in the exercise of the foregoing powers, shall be referred to as the “ Administrator .”

 

(b)            Subject to the express provisions and limitations of this Plan, the Administrator shall be authorized and empowered to do all things necessary or desirable, in its sole discretion, in connection with the administration of the Plan, including, without limitation, the following:

 

(i)                                      To prescribe, amend and rescind rules and regulations relating to the Plan and to define terms not otherwise defined herein, and to take or approve such further actions as it determines necessary or appropriate to the administration of the Plan, such as correcting a defect or supplying any omission, or reconciling any inconsistency so that the Plan or any award complies with applicable law, regulations and listing requirements and so as to avoid unanticipated consequences or address unanticipated events deemed by the Administrator to be inconsistent with the purposes of the Plan;

 

(ii)                                   To designate Participants and to determine the Annual Incentive Payments, if any, to be made to such Participants;

 

(iii)                                To prescribe and amend the terms of any agreements or other documents under the Plan;

 

(iv)                               To determine whether, and the extent to which, adjustments are required pursuant to Section 5;

 

(v)                                  To interpret and construe the Plan, any rules and regulations under the Plan, and the terms and conditions of any Annual Incentive Payment provided hereunder, and to make exceptions to any such provisions in good faith and for the benefit of the Company; and

 



 

(vi)                               To make all other determinations deemed necessary or advisable for the administration of the Plan.

 

(c)            All decisions, determinations and interpretations by the Administrator regarding the Plan and Annual Incentive Payments shall be final and binding on all Participants. The Administrator shall consider such factors, as it deems relevant to making such decisions, determinations and interpretations including, without limitation, the recommendations or advice of any director, officer or employee of the Company and such attorneys, consultants and accountants as it may select.

 

4.              Target Bonus and Earned Bonus

 

(a)            Each Participant will have a target incentive opportunity, stated as a percentage of annual base salary.

 

(b)            A Participant’s annual base salary for the performance period in effect as of April 30 of the applicable performance period, as reflected in the Company’s payroll records, will be used to calculate the earned bonus; provided, however, (i) for terminations under Section 6(a)(i) or (iii) hereof prior to April 30 of the performance period, the annual base salary in effect as of the date of termination and (ii) for a new hire under Section 7(a) hereof that is hired after April 30, the annual base salary in effect on the date of hire. The annual base salary shall include any salary reduction contributions made to the Company’s 401(k) plan or other deferred compensation plans, but shall be exclusive of any awards under the Plan or any other bonus, incentive or special pay awards.

 

(c)            No Participant shall earn an Annual Incentive Payment for a performance period in excess of $10,000,000.

 

(d)            No Annual Incentive Payment shall be paid to a Participant unless he or she is an employee of the Company as of the payment date of the Annual Incentive Payment, except as permitted by Section 6 hereof.

 

(e)            Financial results for Company performance measures must be finalized as appropriate by the Chief Financial Officer using financial results certified by an independent registered public accounting firm before bonuses can be calculated and paid.  Further, no payments will be made unless and until he Administrator certifies in writing or resolves to approve payments generally in accordance with the Plan.  Annual Incentive Payments shall be made in cash.

 

(f)             Notwithstanding any other provision of this Plan, the bonus for a fiscal year (including a pro rata portion of a bonus for a fiscal year under Section 6 hereof) will be paid sometime during (but no later than the last day of) the next following fiscal year;  provided, however, that (i) the date during such next following fiscal year on which a bonus is paid to any “specified employee” under the circumstances described in Section 6(e) hereof may not be earlier than the earliest payment date permitted under Section 6(e) hereof, (ii) in the case of a Change in Control and termination of a Participant’s employment within six months thereafter, the bonus for the fiscal year in which the employment termination occurs shall be paid at the time specified in Section 6(d) hereof, and (iii) a bonus may be paid after the last day of the fiscal year next following the fiscal year to which the bonus relates if and to the extent such deferral of payment of the bonus would not result in the employee incurring additional tax liability on the bonus under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (“ Code Section 409A ”).

 

2



 

5.              Performance Measures

 

(a)            The performance period shall be the Company’s fiscal year.

 

(b)            A Participant’s Annual Incentive Payment shall be based upon the achievement of the Company’s revenue and Adjusted EBITDA, and the Participant’s individual objectives. The Company performance measures for Other Participants may be based on the achievement of a portion of the Company’s revenue and Adjusted EBITDA relating to that portion of the Company’s business the performance of which a Participant can reasonably influence (such as a segment, business unit, division, product line or similar group).

 

(c)            The performance goals may be measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, or compared to previous years’ results or to a designated comparison group, in each case as specified and weighted by the Administrator.

 

(d)            If an unusual or extra-ordinary event significantly impacts the performance goals, the Administrator has the discretion to adjust the goals as appropriate.

 

(e)            Notwithstanding the attainment of financial results, all earned bonuses under the Plan are subject to reduction or elimination by the Administrator prior to payment.  For example, a reduction in any and all earned bonuses may be made if earnings are achieved in ways that are considered not in the best interests of the Company’s shareholders or not authorized by the Board of Directors or management.

 

(f)             The Administrator reserves the right to apply subjective, discretionary criteria to determine the individual performance objectives and performance thereof.

 

6.              Termination of Employment; Change in Control .

 

(a)            Death or Disability During the Plan Period .

 

(i)                                      If a Participant’s employment is terminated due to death, the bonus will be earned and paid (to the estate of the Participant) on a pro rata basis.  The pro rata period will be from the beginning of the Plan period until the date of death.

 

(ii)                                   A Participant’s disability of 30 calendar days or less will not have an impact on the Participant’s eligibility to earn a full bonus under the Plan.

 

(iii)                                If a Participant’s disability lasts more than 30 calendar days, then a bonus may be earned only for fiscal quarters in which the Participant works more than 60 calendar days and will be earned on a pro rata basis for days worked in the applicable fiscal quarters.

 

(b)            Voluntary Termination .  If a Participant’s employment is terminated due to a voluntary termination, including retirement, no bonus will be earned by or paid to the Participant.

 

(c)            Involuntary Termination .  If a Participant’s employment is terminated due to an involuntary termination, including but not limited to due to unsatisfactory performance or cause (but excluding any other event otherwise described in this Section 6), no bonus will be earned by or paid to the

 

3



 

Participant.  For purposes of the Plan, “cause” for termination means any violation of laws or regulations or material violation of Company policies and procedures.

 

(d)            Change in Control . If there is a Change in Control (as defined under the Company’s 2014 Omnibus Incentive Plan, as amended, or any successor equity incentive plan) and the Participant is terminated by the Company (or any successor thereof, by merger, acquisition or otherwise) for any reason within six months of such Change in Control, a Participant shall earn the target award percentage for the fiscal year in which the employment termination occurs multiplied by the greater of his or her actual base salary in effect on the date of (i) the employment termination and (ii) the Change in Control.  Such payments shall be paid in cash to the Participant as soon as administratively possible, but not later than 30 days following such termination.

 

(e)            Section 409A .  Notwithstanding anything in this Plan to the contrary, if it is determined that any payment hereunder constitutes “nonqualified deferred compensation” that would be paid upon “separation from service” of a “specified employee” (as such terms are defined in Section 409A of the Internal Revenue Code of 1986, as amended), then such payment that otherwise would have been paid within six months after the Participant’s “separation from service” shall be accrued, without interest, and its payment delayed until the first day of the seventh month following the Participant’s “separation from service,” or if earlier, the Participant’s death, at which point the accrued amount will be paid as a single, lump sum cash payment.

 

(f)             Timing of Payments .  Except as set forth in Section (6)(d) hereof, earned bonuses under this Section 6 will be paid to Participants approximately at the same time as bonuses are made to other Participants who work for the Company through the end of the fiscal year.

 

(g)            Other Participants .  Notwithstanding anything in Sections 6(a) — (d) hereof, the Administrator may establish separate rules and guidelines for Other Participants in its sole discretion regarding the Annual Incentive Payment payable, if any, in the case of the retirement, termination, death or disability, or in the case of a Change in Control of the Company, prior to the end of a performance period, and the persons to whom such payments shall be made.

 

7.              Pro Rata Bonuses .

 

(a)            New Hires .  A new employee who becomes a Participant in connection with such hire will earn a pro rata bonus from the date of hire.

 

(b)            Transfer; Promotion; Demotion .

 

(i)                                      For an existing employee who is transferred to a new position which results in such employee becoming a Participant, the pro rata period will begin from the date of transfer.

 

(ii)                                   For an existing employee who was a Participant prior to a promotion and who continues to be a Participant thereafter, and the target incentive opportunity, stated as a percentage of annual base salary is increased, the earned bonus will be based on two pro rata periods: (i) from the beginning of the Plan period through the date immediately preceding such promotion, and (ii) from the date of such promotion until the end of the Plan period, in each case based on the base salary, bonus targets and performance goals in effect as of the end of the applicable period.

 

(iii)                                For an existing employee who was a Participant and who is demoted such that the employee is no longer a Participant thereafter, the pro rata period will end on the date

 

4



 

immediately preceding such demotion based on the bonus target and performance goal in effect as of the end of the applicable period.

 

(c)            Achievement of Full Year Performance Measure .  A pro rata bonus will be earned only if the applicable performance goals also are satisfied for the full fiscal year (or other applicable measurement period).  Therefore, no pro rata bonuses with respect to a Company performance measure will be earned if a Participant for the full fiscal year does not earn a bonus with respect to such Company performance measure.

 

(d)            Timing of Pro Rata Payments .  Earned pro rata bonuses under this Section 7 will be paid to Participants approximately at the same time as bonuses are made to other Participants who work for the Company through the end of the fiscal year.

 

(e)            Other Participants .  Notwithstanding anything in Sections 7(a) or (b) hereof, the Administrator may establish separate rules and guidelines for employees that become Other Participants after the beginning of the Company’s fiscal year or are transferred, promoted or demoted.

 

8.              Bonus Clawback .

 

If the Company’s financial statements are the subject of a restatement due to error or misconduct, to the extent permitted by governing law, the Company is authorized under this Plan to seek reimbursement of excess incentive cash compensation paid under the Plan to Participants for the relevant performance periods; provided, this Section 8 only shall apply to any bonuses earned for the three completed fiscal years prior to the date the Company determines such restatement is required. For purposes of this Plan, excess incentive cash compensation means the positive difference, if any, between (i) the Annual Incentive Payment paid to the Participant and (ii) the Annual Incentive Payment that would have been made to the Participant had the performance been calculated based on the Company’s financial statements as restated. The Company will not be required to award Participants an additional Annual Incentive Payment should the restated financial statements result in a higher Annual Incentive Payment.

 

9.              General

 

(a)            Amendment and Termination . The Company reserves the right to amend or terminate this Plan at any time by action of the Board of Directors or the Committee with respect to future services of Participants.

 

(b)            Tax Withholding .  The Company shall have the right to make all payments or distributions pursuant to the Plan to any person, net of any applicable federal, state and local payroll or withholding taxes, or the applicable taxes of any foreign jurisdiction (collectively, “ Taxes ”), required to be paid or withheld. The Company shall have the right to withhold from wages or other amounts otherwise payable to such Participant such Taxes as may be required by law, or if permitted by law, to otherwise require the Participant to pay such Taxes. If such person shall fail to make such Tax payments as are required, the Company shall, to the extent permitted by law, have the right to deduct any such Taxes from any payment of any kind otherwise due to such Participant or to take such other action as may be necessary to satisfy such Tax obligations.

 

(c)            No Assignment . Unless the Committee expressly provides otherwise in writing, no Participant nor any other person may sell, assign, convey, gift, pledge or otherwise hypothecate or alienate any Annual Incentive Payment.

 

5



 

(d)            Non-Exclusivity . The adoption of the Plan by the Board of Directors shall not be construed as creating any limitations on the power of the Board of Directors or Administrator to adopt such other incentive arrangements as either may deem desirable, including, without limitation, cash or equity-based compensation arrangements, either tied to performance or otherwise, and any such other arrangements as may be either generally applicable or applicable only in specific cases.

 

(e)            Employment at Will . Neither the Plan, the selection of a person as a Participant, the payment of any Annual Incentive Payment to any Participant, nor any action by the Company or the Administrator shall be held or construed to confer upon any person any right to be continued in the employ of the Company. The Company expressly reserves the right to discharge any Participant whenever in the sole discretion of the Company its interest may so require.

 

(f)             No Vested Interest or Right .  Except as permitted by Section 6 hereof, at no time before the actual payment of an Annual Incentive Payment to any Participant or other person shall any Participant or other person accrue any vested interest or right whatsoever under the Plan, and the Company has no obligation to treat Participants identically under the Plan.

 

(g)            Beneficiary Designation .  Each Participant may name, from time to time, any beneficiary (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit.  Each designation will revoke all prior designations by the same Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Company during his or her lifetime.

 

(h)            Headings .  Headings are given to the sections and subsections of the Plan solely as a convenience to facilitate reference.  Such headings shall not be deemed in any way material or relevant to the construction or interpretation of the Plan or any provision thereof.

 

(i)             Governing Law .  The Plan and any agreements and documents hereunder shall be governed, construed and administered in accordance with the laws of the State of Michigan (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws of such jurisdiction or any other jurisdiction) and applicable federal law.

 

(j)             Code Section 409A . It is intended that this bonus plan comply with Code Section 409A, and the plan shall be interpreted and administered consistent with that intent; provided, however, that under no circumstances whatsoever shall the Company be liable for any additional tax, interest or penalty imposed upon a participant, or any other damage suffered by a participant, on account of the bonus plan not being in compliance with Code Section 409A.

 

6